(NASDAQ: PGNY) Progyny's forecast annual revenue growth rate of 10.77% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.07%.
Progyny's revenue in 2026 is $1,268,689,000.On average, 13 Wall Street analysts forecast PGNY's revenue for 2026 to be $122,937,818,604, with the lowest PGNY revenue forecast at $115,954,674,630, and the highest PGNY revenue forecast at $133,886,698,662. On average, 12 Wall Street analysts forecast PGNY's revenue for 2027 to be $136,473,048,282, with the lowest PGNY revenue forecast at $126,472,496,418, and the highest PGNY revenue forecast at $153,629,167,428.
In 2028, PGNY is forecast to generate $147,852,986,610 in revenue, with the lowest revenue forecast at $137,248,953,168 and the highest revenue forecast at $157,336,268,550.